Seres Therapeutics Inc (MCRB):企業の財務・戦略的SWOT分析

◆英語タイトル:Seres Therapeutics Inc (MCRB) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH503774FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥76,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥115,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Seres Therapeutics Inc (Seres), is a microbiome therapeutics platform company that develops a novel class of biological drugs. The company creates a new class of medicines to treat diseases resulting from functional deficiencies in the microbiome, a condition known as dysbiosis. The company’s lead development candidate, SER-109 is an oral microbiome therapeutic and bacterial spore ecology that is being developed for the prevention of recurrent clostridium difficile infection in adults. Seres’ SER-287 is an oral therapy for the treatment of ulcerative colitis, an inflammatory bowel disease. The company utilizes its microbiome therapeutics platform to identify key alterations in the microbiome that are associated with or lead to specific diseases. Seres is headquartered in Cambridge, Massachusetts, the US

Seres Therapeutics Inc Key Recent Developments

Mar 12,2021: Seres Therapeutics to Present at the 31st Annual Oppenheimer Healthcare Conference
Mar 02,2021: Seres Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Updates
Feb 26,2021: Seres Therapeutics to Participate in Upcoming Virtual Investor Conferences
Feb 24,2021: Seres Therapeutics to Host Fourth Quarter 2020 Financial Results and Operational Progress Conference Call on March 2, 2021

This comprehensive SWOT profile of Seres Therapeutics Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Seres Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Seres Therapeutics Inc – Key Information
Seres Therapeutics Inc – Overview
Seres Therapeutics Inc – Key Employees
Seres Therapeutics Inc – Key Employee Biographies
Seres Therapeutics Inc – Key Operational Heads
Seres Therapeutics Inc – Major Products and Services
Seres Therapeutics Inc – History
Seres Therapeutics Inc – Company Statement
Seres Therapeutics Inc – Locations And Subsidiaries
Seres Therapeutics Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Seres Therapeutics Inc – Business Description
Seres Therapeutics Inc – Corporate Strategy
Seres Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Seres Therapeutics Inc – Strengths
Seres Therapeutics Inc – Weaknesses
Seres Therapeutics Inc – Opportunities
Seres Therapeutics Inc – Threats
Seres Therapeutics Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Seres Therapeutics Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Seres Therapeutics Inc, Key Information
Seres Therapeutics Inc, Key Ratios
Seres Therapeutics Inc, Share Data
Seres Therapeutics Inc, Major Products and Services
Seres Therapeutics Inc, History
Seres Therapeutics Inc, Key Employees
Seres Therapeutics Inc, Key Employee Biographies
Seres Therapeutics Inc, Key Operational Heads
Seres Therapeutics Inc, Other Locations
Seres Therapeutics Inc, Subsidiaries
Seres Therapeutics Inc, Key Competitors
Seres Therapeutics Inc, SWOT Analysis
Seres Therapeutics Inc, Ratios based on current share price
Seres Therapeutics Inc, Annual Ratios
Seres Therapeutics Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Seres Therapeutics Inc (MCRB):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Rackspace Hosting, Inc.:企業の戦略・SWOT・財務情報
    Rackspace Hosting, Inc. - Strategy, SWOT and Corporate Finance Report Summary Rackspace Hosting, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • William Hill plc (WMH):企業の財務・戦略的SWOT分析
    William Hill plc (WMH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • TechnipFMC Plc (FTI):企業の財務・戦略的SWOT分析
    TechnipFMC Plc (FTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Panhandle Oil and Gas Inc (PHX):石油・ガス:M&Aディール及び事業提携情報
    Summary Panhandle Oil and Gas Inc (Panhandle) sells oil, natural gas liquid (NGL) and natural gas produced from non-operated assets through working interests, royalty interests and both in producing oil and natural gas wells and those in the process of being drilled or completed. The company operate …
  • Mercy Health:製薬・医療:M&Aディール及び事業提携情報
    Summary Mercy Health, formerly Catholic Healthcare Partners, is a Catholic non-profit health system. It operates through a network of hospitals, clinics, medical centers and urgent care facilities in Ohio and Kentucky to offer healthcare services across various specialties. Mercy Health also provide …
  • Acorn Energy, Inc. (ACFN)-エネルギー分野:企業M&A・提携分析
    Summary Acorn Energy, Inc. (Acorn) is an energy technology holding company which operates electricity delivery, emergency back-up power generation, and remote monitoring and control systems through its subsidiaries. The company develops and produces sonar systems for the defense, HLS, energy and com …
  • Sempra Energy:企業の戦略・SWOT・財務情報
    Sempra Energy - Strategy, SWOT and Corporate Finance Report Summary Sempra Energy - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Trammo Inc.:企業の戦略・SWOT・財務情報
    Trammo Inc. - Strategy, SWOT and Corporate Finance Report Summary Trammo Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Pregis LLC.:企業の戦略・SWOT・財務情報
    Pregis LLC. - Strategy, SWOT and Corporate Finance Report Summary Pregis LLC. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • The Capital Group Companies, Inc.:企業の戦略・SWOT・財務情報
    The Capital Group Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Capital Group Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Cell Medica Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Cell Medica Ltd (Cell Medica), formerly Immunocode Ltd manufactures and commercializes cellular products. The company uses various technology platforms such as chimeric antigen receptor (CAR), Dominant T cell receptor (TCR), PENTRA Antibody technology and NKT cell platform for manufacturing …
  • Honeywell International Inc.:企業の戦略・SWOT・財務情報
    Honeywell International Inc. - Strategy, SWOT and Corporate Finance Report Summary Honeywell International Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Pharma Mar SA (PHM)-製薬・医療分野:企業M&A・提携分析
    Summary Pharma Mar SA (Pharma Mar) is a biopharmaceutical company that discovers, develops and markets marine-derived drugs to treat cancer. The company’s marketed product Yondelis (trabectedin), a novel, multimodal, synthetically produced antitumor agent, is indicated for the treatment of advanced …
  • Vedanta Resources Ltd:企業の戦略的SWOT分析
    Vedanta Resources Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • China Evergrande Group:企業のM&A・事業提携・投資動向
    China Evergrande Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's China Evergrande Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • S-Oil Corporation Inc (010950):石油・ガス:M&Aディール及び事業提携情報
    Summary S-Oil Corporation Inc (S-Oil) is a service driven company that operates in the petroleum and petrochemical industry. The company imports and exports crude oil; as well as manufactures and sells oil refining products, petrochemical products and lube products. S-Oil also produces a wide range …
  • CSX Corp (CSX):企業の財務・戦略的SWOT分析
    CSX Corp (CSX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Innophos Holdings Inc (IPHS):企業の財務・戦略的SWOT分析
    Innophos Holdings Inc (IPHS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Boise Cascade Company:企業の戦略・SWOT・財務情報
    Boise Cascade Company - Strategy, SWOT and Corporate Finance Report Summary Boise Cascade Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Shopper’S Stop Ltd.
    Shopper'S Stop Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shopper'S Stop Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆